Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03248258 · ClinicalTrials.gov registry record
Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 200
- Enrollment target
NCT03248258 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants.
The verdict
NCT03248258 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Develop a Metastatic Breast Cancer (MBC)-specific electronic Treatment Plans (TP). Phase 1: Aim 1a: Patient interviews along with navigator, nurse, and physician focus group discussions will be used to identify factors that influence decision-making in treatment selection and the optimal approach for sharing information about prognosis and guideline-based care. Identify decisional needs for Shared Decision Making (SDM) in MBC. Investigators will conduct semi-structured interviews/discussion groups with patients, navigators, nurses, and physicians to elements important to decision-making. Phase 2: Aim 1b: Develop MBC-specific TP. Investigators will build upon Aim1a to systematically develop the TP intervention using the Ottawa Decision Support Framework. Investigators will test the TPs with 5 patients and conduct qualitative investigations to refine the TP using an iterative process. Phase 3:Further explore decision-making related to reducing amount of chemotherapy for patients with good prognosis.
Interventions
- OTHER Qualitative Interview or Focus group discussions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-06-27 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03248258
The ClinicalTrials.gov registry entry for NCT03248258 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Qualitative Interview or Focus group discussions is the first listed.
NCT03248258 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03248258 about?
NCT03248258 is a clinical study titled "Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)". Develop a Metastatic Breast Cancer (MBC)-specific electronic Treatment Plans (TP). Phase 1: Aim 1a: Patient interviews along with navigator, nurse, and physician focus group discussions will be used to identify factors that influence decision-making in treatment selection and the optimal approach ...
What is the current status of trial NCT03248258?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2017-06-27. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT03248258?
The interventions under investigation include: Qualitative Interview or Focus group discussions (OTHER).
Who is sponsoring clinical trial NCT03248258?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.